Search Results

In this episode of Denatured, BioSpace’s Head of Insights Lori and guests from Teva Pharmaceuticals and TOWER Capital Group discuss how critical it is to incorporate women into leadership positions and board rooms as a sound investment strategy.

In this episode of Denatured, BioSpace’s Head of Insights Lori and guests from Teva Pharmaceuticals and TOWER Capital discuss the opportunities, regulatory challenges and uncertainty surrounding AI.

A comprehensive national poll conducted by FTP Insights and Accelerate Advocacy has revealed significant insights into American voters’ perceptions of Alzheimer’s disease, highlighting widespread concern and the urgent need for increased awareness and innovative treatments.

10x Genomics, Inc., a leader in single cell and spatial biology, announced that its Xenium In Situ platform was used in a study published in the Journal of Dental Research, offering novel insights into cellular mechanisms regulating the formation of the secondary palate.

This webinar will help you discover effective strategies for launching your career in biotechnology. You will gain valuable insights from industry experts and leave with the essential tools you need to thrive in this dynamic field.

ABVC BioPharma, Inc., a clinical-stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, CNS, and ophthalmology, proudly announced that its CEO, Dr. Uttam Patil, was selected as one of the Top 10 CEOs in Taiwan 2024 by CEO Insights Asia Magazine.

Rayonier Advanced Materials Inc. today announced that President and Chief Executive Officer, De Lyle Bloomquist, will meet with investors in one-on-one settings as well as a group presentation at the Stifel Cross Sector Insight Conference on June 5, 2024.

ArcScan, Inc. announced that ArcScan Insight® 100 has received National Medical Products Administration approval in China.

Vizient, Inc. hosted its inaugural Insight: Cell, Gene, and Specialty Pharmacy Symposium, bringing together leading healthcare providers, payers and manufacturers of high-cost, ultra-specialty pharmaceuticals along with other stakeholders to discuss the promise and unique challenges of the rapidly expanding market of cell, gene and other advanced therapies.